Cardiac effects of isoliquiritigenin

Wegener J, Nawrath H (1997)
European Journal of Pharmacology 326(1): 37-44.

Zeitschriftenaufsatz | Veröffentlicht | Englisch
 
Download
Es wurden keine Dateien hochgeladen. Nur Publikationsnachweis!
Autor*in
Wegener, JörgUniBi ; Nawrath, Hermann
Abstract / Bemerkung
The effects of isoliquiritigenin on force of contraction (Fc), L-type Ca2+ current (ICa) and intracellular Ca2+ concentration ([Ca2+]i) were investigated in rat ventricular heart muscle. Isoliquiritigenin increased Fc and ICa and, after longer exposure times, resting tension and [Ca2+]i. The effect of isoliquiritigenin (100 μM) on ICa was diminished by Rp-cAMPS (30 μM). 1H-[1,2,4]oxa-diazolo[4,3-a]quinoxalin-1-one (50 μM) did not influence the effects of isoliquiritigenin on Fc and ICa. The positive inotropic effects of isoprenaline and forskolin, but not of 3-isobutyl-1-methylxanthine, were potentiated by isoliquiritigenin (100 μM). In the presence of milrinone (10 μM), no further effects of isoliquiritigenin (100 μM) on Fc and ICa were observed. It is suggested that the increase in Fc and ICa by isoliquiritigenin is due to an accumulation of cyclic AMP. These effects are probably unrelated to an effect of the drug on soluble guanylyl cyclase, as reported for smooth muscle, but rather due to a direct inhibition of phosphodiesterase III activity.
Erscheinungsjahr
1997
Zeitschriftentitel
European Journal of Pharmacology
Band
326
Ausgabe
1
Seite(n)
37-44
ISSN
00142999
Page URI
https://pub.uni-bielefeld.de/record/2984510

Zitieren

Wegener J, Nawrath H. Cardiac effects of isoliquiritigenin. European Journal of Pharmacology. 1997;326(1):37-44.
Wegener, J., & Nawrath, H. (1997). Cardiac effects of isoliquiritigenin. European Journal of Pharmacology, 326(1), 37-44. https://doi.org/10.1016/S0014-2999(97)00134-9
Wegener, Jörg, and Nawrath, Hermann. 1997. “Cardiac effects of isoliquiritigenin”. European Journal of Pharmacology 326 (1): 37-44.
Wegener, J., and Nawrath, H. (1997). Cardiac effects of isoliquiritigenin. European Journal of Pharmacology 326, 37-44.
Wegener, J., & Nawrath, H., 1997. Cardiac effects of isoliquiritigenin. European Journal of Pharmacology, 326(1), p 37-44.
J. Wegener and H. Nawrath, “Cardiac effects of isoliquiritigenin”, European Journal of Pharmacology, vol. 326, 1997, pp. 37-44.
Wegener, J., Nawrath, H.: Cardiac effects of isoliquiritigenin. European Journal of Pharmacology. 326, 37-44 (1997).
Wegener, Jörg, and Nawrath, Hermann. “Cardiac effects of isoliquiritigenin”. European Journal of Pharmacology 326.1 (1997): 37-44.
Export

Markieren/ Markierung löschen
Markierte Publikationen

Open Data PUB

Suchen in

Google Scholar